These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16584365)

  • 1. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study.
    Davis TM; Davis Cyllene Uwa Edu Au WA; Bruce DG
    Med J Aust; 2006 Apr; 184(7):325-8. PubMed ID: 16584365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study.
    Davis TME; Chubb SAP; Curtis BH; Barraclough H; Davis WA
    Intern Med J; 2018 Oct; 48(10):1215-1221. PubMed ID: 29230931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.
    Davis WA; Bruce DG; Davis TM
    Diabetes Care; 2006 Aug; 29(8):1764-70. PubMed ID: 16873777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study.
    Calvert MJ; McManus RJ; Freemantle N
    Fam Pract; 2007 Jun; 24(3):224-9. PubMed ID: 17488736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study.
    Calvert MJ; McManus RJ; Freemantle N
    Br J Gen Pract; 2007 Jun; 57(539):455-60. PubMed ID: 17550670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy.
    Andersen CD; Bennet L; Nyström L; Lindblad U; Lindholm E; Groop L; Rolandsson O
    Diabetologia; 2013 Feb; 56(2):252-8. PubMed ID: 23096095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.
    Eliasson B; Eeg-Olofsson K; Cederholm J; Nilsson PM; Gudbjörnsdóttir S;
    Diabetes Metab; 2007 Sep; 33(4):269-76. PubMed ID: 17499541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.
    Lankisch MR; Ferlinz KC; Leahy JL; Scherbaum WA;
    Diabetes Obes Metab; 2008 Dec; 10(12):1178-85. PubMed ID: 19040645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
    Marre M; Pinget M; Gin H; Thivolet C; Hanaire H; Robert JJ; Fontaine P
    Diabetes Metab; 2009 Dec; 35(6):469-75. PubMed ID: 19914118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequalities in glycaemic control in patients with Type 2 diabetes in primary care.
    Bebb C; Kendrick D; Stewart J; Coupland C; Madeley R; Brown K; Burden R; Sturrock N
    Diabet Med; 2005 Oct; 22(10):1364-71. PubMed ID: 16176198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study.
    Aas AM; Bergstad I; Thorsby PM; Johannesen O; Solberg M; Birkeland KI
    Diabet Med; 2005 Mar; 22(3):316-22. PubMed ID: 15717881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.
    Davis TME; Bruce DG; Finn J; Curtis BH; Barraclough H; Davis WA
    Diabetes Obes Metab; 2019 Mar; 21(3):648-657. PubMed ID: 30370611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications.
    Eppens MC; Craig ME; Jones TW; Silink M; Ong S; Ping YJ;
    Curr Med Res Opin; 2006 May; 22(5):1013-20. PubMed ID: 16709323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health outcomes for diabetes patients returning for three annual general practice checks.
    Tomlin A; Dovey S; Tilyard M
    N Z Med J; 2007 Apr; 120(1252):U2493. PubMed ID: 17460743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events.
    Farmer A; Balman E; Gadsby R; Moffatt J; Cradock S; McEwen L; Jameson K
    Curr Med Res Opin; 2008 Nov; 24(11):3097-104. PubMed ID: 18828957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
    Dornhorst A; Lüddeke HJ; Sreenan S; Kozlovski P; Hansen JB; Looij BJ; Meneghini L;
    Int J Clin Pract; 2008 Apr; 62(4):659-65. PubMed ID: 18324957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Batty KT; Davis TM;
    Diabetes Care; 2005 Apr; 28(4):771-6. PubMed ID: 15793171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.